ClinicalTrials.gov record
Completed Phase 2 Interventional

Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

ClinicalTrials.gov ID: NCT00059982

Public ClinicalTrials.gov record NCT00059982. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 11:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial Of Perifosine In Locally Advanced, Unresectable Or Metastatic Pancreatic Adenocarcinoma

Study identification

NCT ID
NCT00059982
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • perifosine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2003
Primary completion
Not listed
Completion
Jul 31, 2005
Last update posted
Jun 23, 2013

2003 – 2005

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
Tufts - New England Medical Center Boston Massachusetts 02111
CCOP - Duluth Duluth Minnesota 55805
Mayo Clinic Cancer Center Rochester Minnesota 55905
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
MBCCOP-Our Lady of Mercy Cancer Center The Bronx New York 10466
CCOP - Merit Care Hospital Fargo North Dakota 58122
CCOP - Scott and White Hospital Temple Texas 76508

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00059982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2013 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00059982 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →